Professor Peter Hotez
Peter J. Hotez, MD, PhD is the founding dean of the National School of Tropical Medicine and a professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also the Texas Children’s Hospital Endowed Chair of Topical Pediatrics.
He also services as Director of Texas Children’s Hospital Center for Vaccine Development, and the Baker Institute Fellow in Disease and Poverty at Rice University.
Dr Hotez’s research focuses on developing vaccines for neglected tropical disease such as hookworm infection, schistosomiasis, and Chagas disease. These diseases affect hundreds of millions of children and adults worldwide.
A renowned global health advocate, Dr. Hotez co-founded the Global Network for Neglected Tropical Diseases in 2006 as part of the Clinton Global Initiative.
The Global Network for Neglected Tropical Diseases provides access to essential medicines for more than 450 million people.
Dr Hotez earned an undergraduate degree in molecular biophysics from Yale University in 1980, a PhD in biochemical parasitology from Rockefeller University in 1986, and a MD from Weill Cornell Medical College in 1987.
He completed residency training in paediatrics at Massachusetts General Hospital from 1987 to 1989 and postdoctoral fellowship training in infectious diseases and molecular parasitology at Yale from 1989-1991.
Dr Hotez has authored more than 400 original papers published in New England Journal of Medicine, Lancet, Science, Scientific American, and other journals and is founding Editor-in-chief of PLOS Neglected Tropical Diseases. He has also authored or edited 10 books, including the acclaimed Forgotten People, Forgotten Diseases (ASM Press) and Blue Marble Health: An Innovative Plan to Fight Diseases of the Poor amid Wealth (John Hopkins University Press).
He has also written op-eds and editorials for The New York Times, Los Angeles Times, Washington Post, and the Huffington Post. In 2014 he was selected by the US State Department and White House and US Science Envoy, focusing on science and vaccine diplomacy for the Middle East and North Africa.
Professor Dame Sally Davies (TBC)
Dame Sally was appointed Chief Medical Officer (CMO) for England and Chief Medical Advisor to the UK government in March 2011, having held the post on an interim basis since June 2010. She is an independent adviser to the government on medical matters, with particular responsibilities regarding public health.
Dame Sally advocates globally on AMR. She has spoken on AMR at numerous events including the World Health Assembly side events, the G8 science ministers’ meeting in 2015, the Global Health Security Initiative in 2015, and the UN General Assembly side event in 2016.
She was chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and was for three years the chair of the WHO Strategic and Technical Advisory Group on AMR.
Most recently, Dame Sally has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016.
Dame Sally was a member of the World Health Organization (WHO) Executive Board 2014-2016 and has led delegations to a range of WHO summits and forums since 2004.
She is currently a non-executive director on the boards of: The Institute for Health Metrics and Evaluation; Genomics England Ltd; The Blavatnik School of Government, University of Oxford; The Clinton Health Access Initiative; and UK Research & Innovation. She was formerly on the boards of Cumberland Lodge and Ashridge Business School.
From 2004-2016, Dame Sally was the Chief Scientific Adviser (CSA) for the Department of Health (DH), where she was actively involved in NHS R&D from its establishment and founded the National Institute for Health Research (NIHR).
Dame Sally received her DBE in 2009. She was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, USA in 2015.